CRDF News and Press, Cardiff Oncology Inc. From 03/04/24

2024-03-04 06:51:00 ET 3 Tips for Making a Long Term Penny Stocks Portfolio Investing in penny stocks presents an attractive opportunity for those looking to diversify their investment portfolios with potentially high-reward options. Despite their low price point, penny stocks can offer...

2024-03-03 06:29:00 ET 3 Ways That Penny Stocks Are Related to Cryptocurrency Trading penny stocks and investing in cryptocurrency share several key similarities that attract a diverse range of investors looking for opportunities beyond traditional markets. Both avenues offer the potent...

A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 44.2% to $0.0851 on volume of 271,253,038 shares Fisker Inc. Class A (FSR) fell 27.2% to $0.53 on volume of 253,915,529 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 12.5% to $3.325 on v...

2024-02-29 19:06:16 ET DENVER, Colo., Feb 29, 2024 ( 247marketnews.com )- Cardiff Oncology, Inc. (NASDAQ: CRDF ) reported, after today’s market close, its fourth quarter and full year 2023 financial results, and provided a business update. Cardiff Oncology is trading at $...

Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...

SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will participate in a fireside chat and 1x1 investor ...

2024-02-25 12:00:00 ET More on AstraZeneca, Bristol-Myers, etc. Eli Lilly: Will It Be The First Ever Trillion-Dollar Drug Company? Eli Lilly: Yes, It Is Too Late To Join The Party Eli Lilly: Very Strong Fundamentals, But Market Is Euphoric Phase 3 data for As...

Cardiff Oncology Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in Clinical Cancer Research PR Newswire - Findings from the Phase 1b portion of company's Phase 1b /2 study in second-line KRAS-mutated mCRC highlight the safety and pro...

Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare Conference PR Newswire SAN DIEGO , Nov. 20, 2023 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel ther...

2023-11-02 21:11:03 ET Cardiff Oncology, Inc. (CRDF) Q3 2023 Earnings Conference Call November 02, 2023, 16:30 ET Company Participants Kiki Patel - IR, Gilmartin Group Mark Erlander - CEO Jamie Levine - CFO Conference Call Participants Mark Frahm - TD...